Apoptosis and p53 are not involved in the anti-tumor efficacy of (125)I-labeled monoclonal antibodies targeting the cell membrane.: Running title: 125I-RIT-induced cell death mechanisms

Salomé Paillas 1 Vincent Boudousq 1 Bérengère Piron 1 Nathalie Kersual 1 Manuel Bardiès 2 Nicolas Chouin 3 Caroline Bascoul-Mollevi 4 François-Xavier Arnaud 5 André Pèlegrin 1 Isabelle Navarro-Teulon 1 Jean-Pierre Pouget 1, *
* Auteur correspondant
1 IRCM - U896 Inserm - UM1 - Institut de recherche en cancérologie de Montpellier
2 CRCT - Centre de Recherche en Cancérologie de Toulouse
3 ONIRIS
4 CRLC Val d'Aurelle-Paul Lamarque
5 LAPLACE - LAboratoire PLasma et Conversion d'Energie
Abstract : INTRODUCTION: (125)I-labeled monoclonal antibodies ((125)I-mAbs) can efficiently treat small solid tumors. Here, we investigated the role of apoptosis, autophagy and mitotic catastrophe in (125)I-mAb toxicity in p53(-/-) and p53(+/+) cancer cells. METHODS: We exposed p53(-/-) and p53(+/+) HCT116 cells to increasing activities of internalizing (cytoplasmic location) anti-HER1 (125)I-mAbs, or non-internalizing (cell surface location) anti-CEA (125)I-mAbs. For each targeting model we established the relationship between survival and mean nucleus absorbed dose using the MIRD formalism. RESULTS: In both p53(-/-) and p53(+/+) HCT116 cells, anti-CEA (125)I-mAbs were more cytotoxic per Gy than anti-HER1 (125)I-mAbs. Sensitivity to anti-CEA (125)I-mAbs was p53-independent, while sensitivity to anti-HER1 (125)I-mAbs was higher in p53(-/-) HCT 116 cells, suggesting that they act through different signaling pathways. Apoptosis was only induced in p53(+/+) HCT116 cells and could not explain cell membrane radiation sensitivity. Inhibition of autophagy did not modify the cell response to (125)I-mAbs. By contrast, mitotic death was similarly induced in both p53(-/-) and p53(+/+) HCT116 cells by the two types of (125)I-mAbs. We also showed using medium transfer experiments that γ-H2AX foci were produced in bystander cells. CONCLUSION: Cell membrane sensitivity to (125)I-mAbs is not mediated by apoptosis and is p53-independent. Bystander effects-mediated mitotic death could be involved in the efficacy of (125)I-mAbs binding cell surface receptors.
Keywords : Radioimmunotherapy Auger electrons p53 apoptosis 125I-mAbs
Type de document :
Article dans une revue
Nuclear Medicine and Biology, Elsevier, 2013, epub ahead of print. 〈10.1016/j.nucmedbio.2013.02.001〉
Liste complète des métadonnées
http://www.hal.inserm.fr/inserm-00815724
Contributeur : Yves Le Ster <>
Soumis le : vendredi 19 avril 2013 - 11:49:55
Dernière modification le : mercredi 3 octobre 2018 - 16:02:22
Document(s) archivé(s) le : lundi 3 avril 2017 - 07:46:16

Fichiers

Pouget_Nucl_Med_Biol_9th_Janua...
Fichiers produits par l'(les) auteur(s)

Identifiants

Collections

UNIV-TLSE3 | FNCLCC | VALDAURELLE | UNAM | BS | UNIV-MONTPELLIER

Citation

Salomé Paillas, Vincent Boudousq, Bérengère Piron, Nathalie Kersual, Manuel Bardiès, et al.. Apoptosis and p53 are not involved in the anti-tumor efficacy of (125)I-labeled monoclonal antibodies targeting the cell membrane.: Running title: 125I-RIT-induced cell death mechanisms. Nuclear Medicine and Biology, Elsevier, 2013, epub ahead of print. 〈10.1016/j.nucmedbio.2013.02.001〉. 〈inserm-00815724〉

Exporter

BibTeX TEI DC DCterms EndNote

Partager

Métriques

Consultations de la notice

916

Téléchargements de fichiers

372

Contact

support.ccsd.cnrs.fr
hal.support@ccsd.cnrs.fr
Logo CCSD